IGC Pharma (IGC) Inventory Average (2011 - 2026)
IGC Pharma (IGC) posted quarterly Inventory Average of $639000.0 for Q1 2026, down 54.24% year-over-year from $1.4 million in Q1 2025, and down 1.54% quarter-over-quarter from $649000.0 in Q4 2025.
IGC Pharma (IGC) Inventory Average (2011 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Inventory Average for 15 consecutive years, with $639000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average fell 54.24% year-over-year to $639000.0; the TTM figure through Mar 2026 stood at $639000.0 (down 54.24% YoY), while the FY2026 annual figure was $999000.0, down 31.1% from the prior year.
- Inventory Average fell to $639000.0 in Q1 2026 per IGC's latest filing, from $649000.0 in the prior quarter.
- Across five years, Inventory Average topped out at $4.5 million in Q1 2022 and bottomed at $639000.0 in Q1 2026.
- Historically, Inventory Average has averaged $2.2 million across 5 years, with a median of $1.7 million in 2024.
- On a YoY basis, Inventory Average climbed as much as 11.18% in 2025 and fell as far as 55.9% in 2025.
- IGC Pharma's Inventory Average stood at $3.7 million in 2022, then tumbled by 39.17% to $2.3 million in 2023, then tumbled by 35.47% to $1.5 million in 2024, then sank by 55.9% to $649000.0 in 2025, then fell by 1.54% to $639000.0 in 2026.
- Business Quant data shows IGC's Inventory Average at $639000.0 in Q1 2026, $649000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | 639,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 639,000.00 |
| Dec 31, 2025 | 649,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 2.65 Mn |
| Mar 31, 2023 | 3.20 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 3.69 Mn |
| Jun 30, 2022 | 3.59 Mn |
| Mar 31, 2022 | 4.49 Mn |
| Dec 31, 2021 | 5.46 Mn |
| Sep 30, 2021 | 5.49 Mn |
| Jun 30, 2021 | 5.48 Mn |